Beta Bionics (BBNX) Change in Receivables (2024 - 2026)

Beta Bionics has disclosed Change in Receivables across 3 years of filings, most recently posting -$1.4 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at -$1.4 million, up 53.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 million (up 143.49% YoY), and the FY2025 annual result was $5.2 million, down 32.24% from the prior year.
• Change in Receivables came in at -$1.4 million for Q1 2026 at Beta Bionics, down from $5.6 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $5.6 million in Q4 2025 to a low of -$2.9 million in Q1 2025.
• The 3-year median for Change in Receivables is $1.9 million (2024), against an average of $1.3 million.
• Peak annual rise in Change in Receivables reached 111.23% in 2025, while the deepest fall reached 253.08% in 2025.
• Beta Bionics' Change in Receivables stood at $4.6 million in 2024, then rose by 22.75% to $5.6 million in 2025, then plunged by 124.45% to -$1.4 million in 2026.
• The last three Change in Receivables figures came in at -$1.4 million (Q1 2026), $5.6 million (Q4 2025), and $168000.0 (Q3 2025), per Business Quant data.